Singapore - Quality and Uniformity Differentiates Healthcare ServicesBy: Shushmul Maheshwari
|
Singapore - Quality and Uniformity Differentiates Healthcare Services
|
Write a Review
Add to My Favorite
Refer it to Friend
Report Broken Link
|
Medical tourism industry in Singapore is expected to grow at a CAGR of 9.1% through 2012 to generate total revenue of nearly US$ 1700 Million, said “Asian Medical Tourism Analysis (2008-2012)”, a new research report from RNCOS.
According to the report, although the healthcare cost in Singapore is higher than that in other four major Asian medical tourism markets (India, Malaysia, Philippines and Thailand), the tag of the most developed market gives competitive advantage to its medical tourism market. Besides, the quality of healthcare services in Singapore is much better than other Asian markets; in fact, it is equivalent to the US and Western Europe in some cases, helping the Singaporean medical tourism market to grow.
The other reason why Singapore scores over other Asian majors like Thailand and India is that unlike these countries, where there is a wide gap in infrastructure, resources and hygiene between government and private hospitals, the quality healthcare services provided in Singapore are more or less uniform.
In addition, Singapore is famous worldwide for its rich and diverse cultural heritage that attracts international patients who not only get excellent healthcare service, but also visit some of the unique tourist attractions ranging from spa treatments to golf courses. Another key factor that draws patients to Singapore is a wide spectrum of healthcare services that spread from primary health screening to highly complex (quaternary care) services such as organ transplants and step down recovery program.
“Asian Medical Tourism Analysis (2008-2012)” is a thorough study of the five biggest Asian medical tourism markets (Singapore, India, Thailand, Philippines and Malaysia). It provides comprehensive information comprising statistical data and analysis on the past, present and future potential of these markets. The report also discusses the market size, tourist arrivals, infrastructure, accreditations, cost, and success and risk factors.
The research highlights the fact that all the five Asian markets are different from each other in every segment, including cost, human resources, infrastructure, patient perceptions, competencies and government support.
It also provides forecast on various segments such as medical tourism market by country and medical tourists arrivals by country so that investors can align their investment plans according to the chosen market.http://www.rncos.com/Report/IM105.htm |
|
| Keywords |
Asian Medical Tourism Analysis (2008-2012), Medical Tourism Industry Reports, Asian Medical Tourism, Medical Tourism in Asia, Medical Tourism Industry in Asia, Medical Tourism, Asian Medical Tourism Market |
| Category |
Health and Fitness |
| Submission Date |
May 21, 2009 |
| Article Contact Name |
Shushmul Maheshwari || send email to Shushmul Maheshwari
|
|
Other links at Health and Fitness |
| 1. |
Bowel Cleansing the some Natural Way tips
|
|
|
Colon or our large intestines never stop on working and digesting our foods because as soon as they stop, this will cause fatal problems in our body. Bowel Cleansing the Natural Way is one effective method to prevent this from happening. We definitely do not need to spend money in cleansing our stomach because we can actually do it naturally. Here is how you do it right:
1. To detoxify one's belly, you must fuel your body with a lot of fluid or water so that it can help your colon digest the foods that may block your digestive system. The amount of water that you should have must be half your weight.
2. Bowel Cleansing the Natural Way: it is through drinking natural herbs that have detoxifying power to help us cleanse our stomach. Examples include green tea, ginger and turmeric juices, and acai berry drinks.
3. Eating a lot of fresh fruits and vegetables rich in fiber is also a good way to cleanse our body. This may include eating acai berries, oranges, grapes, broccoli, carrots, and cauliflowers among others.
4. Stop eating foods with chemicals and added preservatives, sugar, caffeine, tobacco, and alcohol as these things only end up in our body as toxins.
5. Being physically active is also another form of bowel cleansing the natural way like doing yoga or walking at least thrice a week as it helps you flush toxins in your belly.
Now you want to have more energy, be Healthier, look Younger, lose weight, and cleanse your body, right?
|
| 2. |
Protocol Link, Inc
|
|
|
Protocol Link, Inc. is a leading global project management and consulting firm offering comprehensive advisory services to regulated life sciences companies worldwide, including regulatory compliance, validation, and quality assurance services.
At Protocol Link, we strive to offer the best of both quality and efficiency. It’s how we’ve been doing business since 1996. The right way. Knowing that our clients are counting on us. We have maintained our track record of doing our very best to get it right the first time, every time, for 11-plus years. 95% of our business represents repeat engagements with satisfied clients, reflecting our client focus.
We offer an even balance of regulatory expertise and experience. Our consultants are hands-on, analytical, yet strategic. We are driven by providing the best solutions to help our clients meet their business goals. With more than 450 projects completed to date, representing engagements in the US, Australia, Belgium, France, Germany, Italy, Japan, Mexico, The Netherlands, Puerto Rico, Romania, and South Korea, Protocol Link is building a strong worldwide presence. Over the years we have successfully managed projects and advised dozens of firms ranging from Fortune 50 companies to start-up biotechnology firms by offering the following list of specialties:
Services Knowledge
Compliance Planning and Management
Compliance and Readiness Audits
Quality Systems Development
Validation (Plans, Systems, Processes)
CGMP / QA Documentation
Regulatory Affairs & Submission Assistance
Technical Services
Training Programs
Exception Investigations and CAPA
FDA and EU Liaison
Inspectional Observations Preparation Critical Systems / Facilities
Computer Systems
SVP and LVP Processes
Solid Dosage Manufacturing
Packaging and Labeling
Cleaning Processes
Analytical Method Development
Laboratory Controls
Diagnostics and Medical Devices
Contract Manufacturing Oversight
Change Control / Change Management
We invite you to visit our Web site at www.protocollink.com for additional information about our company and the services that we offer. We look forward to serving you.
|
| 3. |
India to Conduct 5% Global Clinical Trials by 2012
|
|
|
India is fast becoming one of the biggest hubs for conducting global clinical trials. In 2007, the country conducted around 220 clinical trials, making up for less than 2% of the global clinical trials But according to “Booming Clinical Trials Market in India”, a new research report by RNCOS, a number of factors such as low cost, large patient pool, easy recruitment, strong government support and strengthening of its intellectual property environment will enable India to conduct nearly 5% of the global clinical trials by 2012.
As per the report, India scores well above many other destinations in almost every factor analyzed. For instance, India provides one of the largest patient pools for both infectious and chronic diseases. Moreover, the country has 40 million diabetics, representing the largest in any country. Similarly, India also has one of the highest numbers of patients for other chronic diseases such as cardiovascular, neurological disorders, respiratory disorders and obesity. Apart from chronic disorders, the country also provides one of the largest numbers of patients for such infectious diseases as HIV, malaria and tuberculosis.
The findings of the report suggest that not only does India provide a large patient pool, the recruitment of these patients is also among the fastest in the world. As most of the healthcare costs in India are paid “out of pocket”, a large patient population continues to have unmet medical needs. As a result, they readily volunteer to participate in clinical trials to get free treatment.
“Booming Clinical Trials Market in India” gives an extensive and objective analysis on the Indian clinical trials market. It investigates the advantages and disadvantages India has over other countries to become a global clinical trials hub. The report exhaustively evaluates and compares the key factors that drug companies and CROs look before outsourcing clinical trials to a country. These include factors such as patient pool, regulatory environment, cost, infrastructure, human resources and past performance in conducting clinical trials.
Thus, the report serves as a useful guide for drug manufacturers, CROs, consultants and investors who are planning to enter the Indian clinical trials market.
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM564.htm
Check DISCOUNTED REPORTS on: http://www.rncos.com
|
| 4. |
Colonic Irrigation, Slough UK
|
|
|
Meet the expert’s in anatomy and physiology with considerable training and experience in a body-based complementary therapy other than colonic therapy. Expect the remarkably hygienic and clean shop center located at Slough UK.
For your emotional and spiritual ailments there are various massages, therapies and beauty treatments that you on all levels - mind, body and spirit can be treated on.
At Body Peace we provide a wide range of holistic complementary treatments. Body Peace is a well established modern Complementary and Alternative Medicine Clinic specializing in aspects of medicine, from Colon (colonic Irrigation) Hydrotherapy, Allergy/Intolerance testing, Body Detox, Homeopathy, Hypnotherapy(stopping smoking) Psychotherapy, series of health massages etc.. We are located in Maidenhead, Taplow, Berkshire, treatments are from 9.30a.m.-10p.m. 7 days a week.
|
| 5. |
RNCOS Releases a New Report- Japanese Generic Market Forecast to 2013
|
|
|
According to “Japanese Generic Market Forecast to 2013”, a new research report by RNCOS, Japan promises to be one of the most lucrative generic markets in the world. Between 2005 and 2008, the Japanese generics market grew at a CAGR of around 7.5% to register ¥ 333 Billion (US$ 3.5 Billion) in revenue.
The Japanese market is characterized by a strong support by the government, which in a desperate bid to limit its healthcare costs, is introducing a number of generic-friendly policies. Other factors such as a large number of patent expiries and the largely un-penetrated nature of the market are also contributing towards the market growth.
The generic market is presently dominated by domestic manufacturers, with the top six manufacturers accounting for 56% of the total market in 2007. But opening up of the market and introduction of a number of generic-friendly reforms is attracting a number of foreign players in the market.
Despite such a big opportunity for future, the market also has a number challenges to deal with. Generic drugs are still regarded as cheap, low quality alternatives of branded drugs. Thus, both physicians and patients are skeptic regarding their safety and efficacy. A number of awareness and educational programs, however, are expected to increase their awareness in future.
Despite these challenges, our forecast models suggest that the generic drugs market will grow at a CAGR of around 8.8% between 2009 and 2013.
The report gives an extensive and objective analysis on the generic market in Japan. It investigates both the past and present trends in the generic market, but its focus is on the future trends shaping the industry. The report also investigates the performance of various players in the Japanese pharmaceutical and generic markets, and analyzes the competitive landscape in these markets. Based on various present and future indicators, the future scenario of the market has also been analyzed.
Key questions answered in the report
- What is the size and penetration level of the Japanese generic market?
- How is the Japanese generic market different from other developed markets?
- What are the key drivers and challenges for the generic market?
- What is the role of government in the market?
- What is the viewpoint of patients and physicians on generic drugs?
- What is the future outlook of the drug market?
- Who are the key players operating in the Japanese generic market?
Key players operating in Japanese generic market
This report features the key players currently operating in the Japanese pharmaceutical and generic markets. This section describes market shares and growth of key pharmaceutical and generic players in Japan. Profiles of the top six generic manufacturers have been provided in the report.
For more information visit: http://www.rncos.com/Report/IM170.htm
Current Industry News: http://www.rncos.com/Blog/
|
|
|
